Shanghai Allist Pharmaceuticals Co., Ltd. (SHA: 688578)

Shanghai Allist Pharmaceuticals Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 12, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	25,025	18,747	8,856	13,590	12,816	-
Market Cap Growth	41.27%	111.69%	-34.83%	6.04%	-	-
Enterprise Value	21,996	16,494	6,916	11,015	12,083	-
Last Close Price	55.61	41.15	19.44	29.83	28.13	-
PE Ratio	19.30	28.78	67.03	745.80	-33.49	-
PS Ratio	7.81	9.29	11.20	25.64	22849.52	-
PB Ratio	5.15	4.71	2.78	4.57	4.45	-
P/FCF Ratio	20.53	30.90	-169.64	-83.40	-44.94	-
P/OCF Ratio	17.13	27.79	96.65	463.96	-65.14	-
EV/Sales Ratio	6.87	8.17	8.74	20.78	21543.30	-
EV/EBITDA Ratio	16.60	28.12	117.62	-196.69	-34.53	-
EV/EBIT Ratio	17.28	30.01	178.99	-157.79	-33.40	-
EV/FCF Ratio	18.04	27.18	-132.47	-67.60	-42.37	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	0.09
Debt / EBITDA Ratio	0.00	0.00	0.03	-	-	-
Debt / FCF Ratio	0.00	0.00	-0.04	-0.03	-	-0.32
Asset Turnover	0.68	0.52	0.24	0.17	0.00	0.00
Inventory Turnover	3.33	2.32	1.78	1.90	0.03	1.84
Quick Ratio	6.21	7.18	8.62	14.59	23.79	6.60
Current Ratio	6.96	7.46	8.98	15.21	24.58	6.86
Return on Equity (ROE)	30.48%	17.97%	4.24%	0.62%	-15.29%	-63.33%
Return on Assets (ROA)	16.91%	8.79%	0.73%	-1.43%	-10.48%	-29.04%
Return on Capital (ROIC)	18.69%	9.58%	0.78%	-1.49%	-10.84%	-33.18%
Earnings Yield	5.18%	3.44%	1.47%	0.13%	-2.42%	-
FCF Yield	4.87%	3.24%	-0.59%	-1.20%	-2.23%	-
Dividend Yield	0.87%	0.97%	-	-	-	-
Buyback Yield / Dilution	0.28%	-0.09%	1.49%	-23.59%	-2.30%	-
Total Shareholder Return	1.15%	0.88%	1.49%	-23.59%	-2.30%	-

Source: S&P Capital IQ. Standard template. Financial Sources.